Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 35

1.
2.
3.

Papillomas of the breast. A histologic spectrum including atypical hyperplasia and carcinoma in situ.

McKinney CD, Fechner RE.

Pathol Annu. 1995;30 Pt 2:137-78. Review.

PMID:
8570274
4.

Proliferative breast "disease". An unresolved diagnostic dilemma.

Rosen PP.

Cancer. 1993 Jun 15;71(12):3798-807. Review. No abstract available.

5.

Redundant cyclin overexpression and gene amplification in breast cancer cells.

Keyomarsi K, Pardee AB.

Proc Natl Acad Sci U S A. 1993 Feb 1;90(3):1112-6.

6.

Expression and amplification of cyclin genes in human breast cancer.

Buckley MF, Sweeney KJ, Hamilton JA, Sini RL, Manning DL, Nicholson RI, deFazio A, Watts CK, Musgrove EA, Sutherland RL.

Oncogene. 1993 Aug;8(8):2127-33.

PMID:
8336939
7.

Cell cycle. Dams and sluices.

Nasmyth K, Hunt T.

Nature. 1993 Dec 16;366(6456):634-5. No abstract available.

PMID:
8259207
8.
9.

Amplification and overexpression of cyclin D1 in breast cancer detected by immunohistochemical staining.

Gillett C, Fantl V, Smith R, Fisher C, Bartek J, Dickson C, Barnes D, Peters G.

Cancer Res. 1994 Apr 1;54(7):1812-7.

10.

Determination of proliferation index with MIB-1 in advanced ovarian cancer using quantitative image analysis.

Kerns BJ, Jordan PA, Faerman LL, Berchuck A, Bast RC Jr, Layfield LJ.

Am J Clin Pathol. 1994 Feb;101(2):192-7.

11.

Cell cycle control and cancer.

Hartwell LH, Kastan MB.

Science. 1994 Dec 16;266(5192):1821-8. Review.

PMID:
7997877
12.

Cyclins and cancer. II: Cyclin D and CDK inhibitors come of age.

Hunter T, Pines J.

Cell. 1994 Nov 18;79(4):573-82. Review. No abstract available.

PMID:
7954824
13.

Immunohistochemistry of cyclin D1 in human breast cancer.

Zhang SY, Caamano J, Cooper F, Guo X, Klein-Szanto AJ.

Am J Clin Pathol. 1994 Nov;102(5):695-8.

14.

p53 involvement in control of G2 exit of the cell cycle: role in DNA damage-induced apoptosis.

Guillouf C, Rosselli F, Krishnaraju K, Moustacchi E, Hoffman B, Liebermann DA.

Oncogene. 1995 Jun 1;10(11):2263-70.

PMID:
7784074
15.
16.

Determination of the prognostic value of cyclin D1 overexpression in breast cancer.

McIntosh GG, Anderson JJ, Milton I, Steward M, Parr AH, Thomas MD, Henry JA, Angus B, Lennard TW, Horne CH.

Oncogene. 1995 Sep 7;11(5):885-91.

PMID:
7675447
18.

Cyclins as markers of tumor proliferation: immunocytochemical studies in breast cancer.

Dutta A, Chandra R, Leiter LM, Lester S.

Proc Natl Acad Sci U S A. 1995 Jun 6;92(12):5386-90.

19.

Overexpression of cyclin D mRNA distinguishes invasive and in situ breast carcinomas from non-malignant lesions.

Weinstat-Saslow D, Merino MJ, Manrow RE, Lawrence JA, Bluth RF, Wittenbel KD, Simpson JF, Page DL, Steeg PS.

Nat Med. 1995 Dec;1(12):1257-60.

PMID:
7489405
20.

Risk factors for breast cancer in women with proliferative breast disease.

Dupont WD, Page DL.

N Engl J Med. 1985 Jan 17;312(3):146-51.

PMID:
3965932
Items per page

Supplemental Content

Support Center